[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f8Mgo9mxDgaFwUgsNSX99XZd_oXXHKohWTy6DUBywoXk":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":32,"phaseBuckets":33,"rows":40},"Universidad Europea de Madrid",[4],95,false,19,1,6490,0,88,[14,17,20,22,24,26,28,30],{"name":15,"count":16},"Carpal Tunnel Syndrome",6,{"name":18,"count":19},"Cystic Fibrosis in Children",3,{"name":21,"count":19},"Compulsive Sexual Behavior",{"name":23,"count":19},"Hypersexuality",{"name":25,"count":19},"Depression",{"name":27,"count":19},"Healthy",{"name":29,"count":19},"Pain",{"name":31,"count":19},"Multiple Sclerosis",[],[34,35,36,37,38,39],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[41,79,107,145,170,188,206],{"intervention":42,"totalTrials":43,"cells":44},"Gabapentin 300mg",2,{"EARLY_PHASE1":45,"PHASE1":47,"PHASE2":49,"PHASE3":51,"PHASE4":53,"NA":77},{"trials":46,"activeCount":11},[],{"trials":48,"activeCount":11},[],{"trials":50,"activeCount":11},[],{"trials":52,"activeCount":11},[],{"trials":54,"activeCount":11},[55,67],{"nctId":56,"briefTitle":57,"status":58,"phases":59,"primaryCompletion":60,"completion":61,"start":62,"enrollment":63,"conditions":64,"interventions":65},"NCT06781489","Pain Reduction Caused by the Combined Treatment of Physiotherapy, Oral Gabapentin and Oral Ibuprofen Arginine.","COMPLETED",[38],"2025-03-20","2025-03-29","2025-02-19",129,[15],[42,66],"Ibuprofen Arginine",{"nctId":68,"briefTitle":69,"status":58,"phases":70,"primaryCompletion":71,"completion":72,"start":62,"enrollment":73,"conditions":74,"interventions":75},"NCT06778798","Gabapentin and Neural Mobilization Pain Reduction Effect Compared to Only Gabapentine",[38],"2025-03-18","2025-03-25",72,[15],[76,42],"Median nerve neural mobilization and oral gabapentin",{"trials":78,"activeCount":11},[],{"intervention":66,"totalTrials":43,"cells":80},{"EARLY_PHASE1":81,"PHASE1":83,"PHASE2":85,"PHASE3":87,"PHASE4":89,"NA":105},{"trials":82,"activeCount":11},[],{"trials":84,"activeCount":11},[],{"trials":86,"activeCount":11},[],{"trials":88,"activeCount":11},[],{"trials":90,"activeCount":11},[91,95],{"nctId":56,"briefTitle":57,"status":58,"phases":92,"primaryCompletion":60,"completion":61,"start":62,"enrollment":63,"conditions":93,"interventions":94},[38],[15],[42,66],{"nctId":96,"briefTitle":97,"status":58,"phases":98,"primaryCompletion":99,"completion":100,"start":62,"enrollment":101,"conditions":102,"interventions":103},"NCT06778759","Ibuprofen Arginine and Neural Mobilization Versus Ibuprofen Arginine in the Treatment of Carpal Tunnel Syndrome",[38],"2025-03-12","2025-03-19",76,[15],[104,66],"median nerve neural mobilization combined with oral ibuprofen arginine",{"trials":106,"activeCount":11},[],{"intervention":108,"totalTrials":43,"cells":109},"ibuprofen",{"EARLY_PHASE1":110,"PHASE1":112,"PHASE2":114,"PHASE3":116,"PHASE4":129,"NA":143},{"trials":111,"activeCount":11},[],{"trials":113,"activeCount":11},[],{"trials":115,"activeCount":11},[],{"trials":117,"activeCount":11},[118],{"nctId":119,"briefTitle":120,"status":58,"phases":121,"primaryCompletion":122,"completion":122,"start":123,"enrollment":124,"conditions":125,"interventions":127},"NCT02593721","Hypoalgesic Effect of Neural Mobilization Versus Ibuprofen Pharmacologic Treatment",[36,37],"2015-09","2015-07",50,[126],"Cervicobrachial Neuralgia",[128],"Ibuprofen",{"trials":130,"activeCount":11},[131],{"nctId":132,"briefTitle":133,"status":58,"phases":134,"primaryCompletion":135,"completion":136,"start":137,"enrollment":138,"conditions":139,"interventions":142},"NCT04328805","Ibuprofen and Neural Mobilization Treatment in Carpal Tunnel Syndrome.",[38],"2020-12-26","2020-12-29","2020-09-23",123,[15,128,140,141],"Pain Management","Pain, Chronic",[108],{"trials":144,"activeCount":11},[],{"intervention":146,"totalTrials":9,"cells":147},"Gabapentin oral",{"EARLY_PHASE1":148,"PHASE1":150,"PHASE2":152,"PHASE3":154,"PHASE4":156,"NA":168},{"trials":149,"activeCount":11},[],{"trials":151,"activeCount":11},[],{"trials":153,"activeCount":11},[],{"trials":155,"activeCount":11},[],{"trials":157,"activeCount":11},[158],{"nctId":159,"briefTitle":160,"status":58,"phases":161,"primaryCompletion":162,"completion":163,"start":164,"enrollment":165,"conditions":166,"interventions":167},"NCT04285281","Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome",[38],"2020-08-01","2020-08-10","2020-04-01",126,[15],[146],{"trials":169,"activeCount":11},[],{"intervention":104,"totalTrials":9,"cells":171},{"EARLY_PHASE1":172,"PHASE1":174,"PHASE2":176,"PHASE3":178,"PHASE4":180,"NA":186},{"trials":173,"activeCount":11},[],{"trials":175,"activeCount":11},[],{"trials":177,"activeCount":11},[],{"trials":179,"activeCount":11},[],{"trials":181,"activeCount":11},[182],{"nctId":96,"briefTitle":97,"status":58,"phases":183,"primaryCompletion":99,"completion":100,"start":62,"enrollment":101,"conditions":184,"interventions":185},[38],[15],[104,66],{"trials":187,"activeCount":11},[],{"intervention":76,"totalTrials":9,"cells":189},{"EARLY_PHASE1":190,"PHASE1":192,"PHASE2":194,"PHASE3":196,"PHASE4":198,"NA":204},{"trials":191,"activeCount":11},[],{"trials":193,"activeCount":11},[],{"trials":195,"activeCount":11},[],{"trials":197,"activeCount":11},[],{"trials":199,"activeCount":11},[200],{"nctId":68,"briefTitle":69,"status":58,"phases":201,"primaryCompletion":71,"completion":72,"start":62,"enrollment":73,"conditions":202,"interventions":203},[38],[15],[76,42],{"trials":205,"activeCount":11},[],{"intervention":207,"totalTrials":9,"cells":208},"CFTR Modulators",{"EARLY_PHASE1":209,"PHASE1":211,"PHASE2":213,"PHASE3":215,"PHASE4":217,"NA":219},{"trials":210,"activeCount":11},[],{"trials":212,"activeCount":11},[],{"trials":214,"activeCount":11},[],{"trials":216,"activeCount":11},[],{"trials":218,"activeCount":11},[],{"trials":220,"activeCount":11},[221],{"nctId":222,"briefTitle":223,"status":224,"phases":225,"primaryCompletion":226,"completion":227,"start":228,"enrollment":11,"conditions":229,"interventions":230},"NCT04415268","Combined Effect of CFTR Protein Modulator Drugs and Exercise in Cystic Fibrosis","WITHDRAWN",[39],"2021-01-29","2021-05-15","2020-06-09",[18],[207]]